Quick Answer
Guardant Health, Inc. reported Diluted EPS of $3.32 per share (loss) for fiscal year 2025.
Guardant Health, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$3.32 | +6.7% |
| 2024 | -$3.56 | +16.8% |
| 2023 | -$4.28 | +33.2% |
| 2022 | -$6.41 | -60.2% |
| 2021 | -$4.00 | -53.8% |
| 2020 | -$2.60 | -209.5% |
| 2019 | -$0.84 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.74 | +15.9% | +7.5% |
| June 30, 2025 | -$0.80 | +4.8% | -3.9% |
| March 31, 2025 | -$0.77 | +18.1% | +12.5% |
| September 30, 2024 | -$0.88 | -20.5% | -4.8% |
| June 30, 2024 | -$0.84 | -25.4% | +10.6% |
| March 31, 2024 | -$0.94 | +27.7% | -28.8% |
| September 30, 2023 | -$0.73 | +53.8% | -9.0% |
| June 30, 2023 | -$0.67 | +70.2% | +48.5% |
- Guardant Health, Inc. showed an increase of +6.7% in Diluted EPS compared to the prior fiscal year.
- Over the 2019–2025 period, Guardant Health, Inc.’s diluted eps has declined by 295.2% (from $0.84 per share (loss) to $3.32 per share (loss)).
- The most recent figure is from Guardant Health, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: